Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ProPhase Labs, Inc.PRPH · Entity 8699 | Director | October 01, 2018 | October 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ProPhase Labs, Inc.
Report date October 01, 2018 · Filed October 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0005SEC Table I · non-derivative | Direct | 318,282 |
Reported balance
After 2018-10-01 transaction · row 1
1 source rowRow 1 · 2018-10-01 · Grant · Acquired 3,737 · Balance 318,282 F1: These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2018 Filed Oct 2, 2018 21:19 UTC | ProPhase Labs, Inc. PRPH · Entity 8699 | GrantCommon Stock, par value $0.0005 | 3,737 | $3.01 | $11,248.37 |
DisclosureSEC source: 0001493152-18-014008 · ownership.xml · nonDerivative · entry 1 Burnett Mark A. · CIK 0001459576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,282 F1 · shares: These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors. Read SEC document |
| July 19, 2018 Filed Jul 23, 2018 14:08 UTC | ProPhase Labs, Inc. PRPH · Entity 8699 | GrantCommon Stock, par value $0.0005 | 3,737 | $3.01 | $11,248.37 |
DisclosureSEC source: 0001493152-18-010341 · ownership.xml · nonDerivative · entry 1 Burnett Mark A. · CIK 0001459576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,545 F1 · shares: These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.